Skip to main content
Terug
Watch Compare

GENELUX Corp

Datakwaliteit: 100%
GNLX
Nasdaq Manufacturing Chemicals
€ 2,54
▼ € 0,02 (-0,78%)
Marktkapitalisatie: 107,76 M
Prijs
€ 2,41
Marktkapitalisatie
107,76 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -26,37 M
Capital intensive — 13725,00% of revenue goes to capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)0,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-151,31%
Onder sectorgemiddelde (-53,53%)
ROIC-116,31%
Net Margin-401812,50%
Op. Margin-415175,00%

Veiligheid

Debt / Equity
N/A
Current Ratio4,20
Interest CoverageN/A

Waardering

PE (TTM)
-3,35
Onder sectorgemiddelde (-1,48)
P/B Ratio5,80
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -3,4 -1,5
P/B 5,8 1,6
ROE % -151,3 -53,5
Net Margin % -401812,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

6 analisten
Buy
Huidig
€ 2,54
+589.0%
Koersdoel
€ 17,50
€ 10,00
€ 16,00
€ 31,00
Vooruitzicht
Forward K/W -3,09
Forward WPA -€ 0,82
Omzet Sch. 12,22 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,82
-€ 1,08 – -€ 0,56
 12,22 M 4
FY2026 -€ 0,82
-€ 1,11 – -€ 0,69
 0,0 6

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,22 -€ 0,24 -9,9%
Q32025 -€ 0,21 -€ 0,21 +1,6%
Q22025 -€ 0,22 -€ 0,20 +7,4%
Q12025 -€ 0,24 -€ 0,21 +13,4%

ETFs Holding This Stock

CNCR CNCR
2,90% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0,00% Revenue Growth (3Y) -78,31%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 8.000,0 Net Income (TTM) -32,15 M
ROE -151,31% ROA -112,33%
Gross Margin N/A Operating Margin -415175,00%
Net Margin -401812,50% Free Cash Flow (TTM) -26,37 M
ROIC -116,31% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,20
Interest Coverage N/A Asset Turnover 0,00
Working Capital 16,43 M Tangible Book Value 18,59 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,35 Forward P/E N/A
P/B Ratio 5,80 P/S Ratio 13469,75
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24,47%
Market Cap 107,76 M Enterprise Value 107,76 M
Per Share
EPS (Diluted TTM) -0,86 Revenue / Share 0,00
FCF / Share -0,59 OCF / Share -0,56
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 13725,00% FCF Conversion 82,02%
SBC-Adj. FCF -32,22 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 8.000,0 8.000,0 170.000,0
Net Income -32,15 M -29,87 M -28,30 M
EPS (Diluted) -0,86 -0,95 -1,16
Gross Profit — — —
Operating Income -33,21 M -31,70 M -24,17 M
EBITDA — — —
R&D Expenses 19,85 M 19,00 M 12,77 M
SG&A Expenses — — —
D&A — — —
Interest Expense — 173.000,0 —
Income Tax — — 1,10 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 19,03 M 34,72 M 27,89 M
Total Liabilities 7,48 M 8,44 M 8,42 M
Shareholders' Equity 11,54 M 26,27 M 19,47 M
Total Debt — 900.000,0 900.000,0
Cash & Equivalents 5,33 M 8,57 M 9,42 M
Current Assets 15,13 M 31,55 M 24,20 M
Current Liabilities 6,23 M 6,90 M 6,55 M